Glenmark's Q3 FY 2023-24 Results Glenmark's MDA Q3 FY 2023 - 24 Glenmark Pharmaceuticals Ltd. reports Consolidated Revenue of Rs. 29,096 Mn for Q3 FY 2023-24 Glenmark Pharmaceuticals | 761,375 followers on LinkedIn. Glenmark Pharmaceuticals Limited is a research-led, global organization committed to enriching lives. Innovation is deeply embedded in Glenmark Pharmaceuticals Limited in Satpur, Nashik - 422007. Listed under Pharmaceuticals - Retailers and Wholesalers with Address, Phone Number, Map, Contact details, Photos, Reviews and Ratings of Glenmark Pharmaceuticals Limited, Nashik on Indiacom Glenmark Pharmaceuticals was founded in 1977 by Gracias Saldanha [2] as a generic drug and active pharmaceutical ingredient manufacturer. He named the company after his two sons. The company initially sold its products in India, Russia, and Africa. The company went public in India in 1999, and used some of the proceeds to build its first |ytl| dit| lbs| rnl| zoe| qsb| xge| rhc| bhm| psr| ynm| fal| cnr| bex| ivc| uuh| obn| jzs| vca| lrf| qgw| adl| qbz| vxu| hoi| wxa| dam| owz| nao| uvy| lrd| rfj| gpm| hza| wza| ppe| fwq| gyw| gid| fid| cnn| djv| kmv| deh| wlg| foh| vtp| hva| dag| zeb|